CAMERON FRENCH: Open Payments
NPI 1841289469 · RIGBY, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 62 payments from 9 companies in 2025. Trend: 2023 $1,012 · 2024 $1,455 · 2025 $1,020
Food & beverage: $963Education: $58
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $310 |
| Janssen Biotech, Inc. | 13 | $222 |
| Novartis Pharmaceuticals Corporation | 15 | $192 |
| Lilly USA, LLC | 4 | $93 |
| Organon LLC | 6 | $75 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| Galderma Laboratories, L.P. | 1 | $36 |
| UCB, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $19 |
Products named: TREMFYA, COSENTYX, SKYRIZI, RINVOQ, TALTZ, VTAMA, Sotyktu, NEMLUVIO.
Industry payments across ID — which companies pay providers there.
